Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis Institute of Tropical Medicine
We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB): a standardised regimen of 9-12 months (the "shorter regimen") and individualised regimens of >= 20 months ("longer regimens").
We collected individual patient data from observational studies identified through systematic reviews and a public call for ...